New topical serums can reduce pigmentation by nearly 48% in just six weeks, and FDA-approved fillers like Restylane Eyelight show high responder rates and satisfaction
CrossRef Mitochondrial-associated PCD signature defines immune landscape, therapeutic sensitivity, and prognosis in hepatocellular carcinoma Xiao-qin Luo, Yi-min Cao, Yang Peng, Jing Dong, Zhi-yong Chen, Lu-shan Xiao, Wei-zhen Wang, Mei-ling Ai Discover Oncology .2025;[Epub] CrossRef Identification and validation of prognostic markers for cuproptosis-related macrophage polarization genes in hepatocellular carcinoma Xin Deng, Jinying Cao, Yingying Liang, Bo Lyu, Ling Tong Discover Oncology .2025;[Epub] CrossRef Mechanisms of Targeted Drug Delivery for Liver Cancer: Active, Passive, and Subcellular Strategies Yang Tian, Yusheng Shi Journal of Biosciences and Medicines .2025
K.McLeanB
The different receptor profiles may activate pathways that had become less responsive to single-target therapy